k562 human chronic myelogenous leukemia cell line (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
99
Structured Review
ATCC
k562 human chronic myelogenous leukemia cell line
K562 Human Chronic Myelogenous Leukemia Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 11049 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+chronic+myelogenous+leukemia+cell+line+k562/K-562/pm41888396-60-12-19
Average 99 stars, based on 11049 article reviews
K562 Human Chronic Myelogenous Leukemia Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 11049 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+chronic+myelogenous+leukemia+cell+line+k562/K-562/pm41888396-60-12-19
Average 99 stars, based on 11049 article reviews
k562 human chronic myelogenous leukemia cell line - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
other:Article Title: Detoxified pneumolysin derivative ΔA146Ply inhibits autophagy and induces apoptosis in acute myeloid leukemia cells by activating mTOR signaling Article Snippet: The mouse AML cell lines C1498 and Raw264.7, human chronic myelogenous leukemia cell line K562, and human AML cell lines KG-1 and Article Title: Protocol to generate human stem cell-derived CD70-directed allogeneic CAR-NKT cells for treating renal cell carcinoma Article Snippet: Article Title: Protocol to profile tumor and microenvironment from ovarian cancer patient samples and evaluate cell-based therapy using in vitro killing assays Article Snippet: Human chronic myelogenous leukemia cell line K562 , Article Title: Multimodal targeting of metastatic renal cell carcinoma via CD70-directed allogeneic CAR-NKT cells Article Snippet: Multiple Displacement Amplification:Article Title: Trabectedin enhances the antitumor effects of IL-12 in triple-negative breast cancer Article Snippet: IL-12 is a potent NK cell–stimulating cytokine, but the presence of immunosuppressive myeloid cells such as myeloid-derived suppressor cells (MDSC) can inhibit IL-12–induced NK-cell cytotoxicity.. Thus, we hypothesized that trabectedin, a myeloid cell– depleting agent, would improve the efficacy of IL-12 in triplenegative breast cancer (TNBC).. In vitro treatment of healthy donor NK cells with trabectedin increased expression of the activation marker CD69 and mRNA expression of T-box transcription factor (Tbx21), the cytotoxic ligands TNF-related apoptosis–inducing ligand (TNFSF10), Fas ligand (FASLG), and the dendritic cell (DC)– recruiting chemokine lymphotactin (XCL1). Article Title: Trabectedin Enhances the Antitumor Effects of IL-12 in Triple-Negative Breast Cancer Article Snippet: .. Murine TNBC cell lines 4T1 (ATCC Cat. #CRL-2539, RRID: CVCL_0125) and EMT6 (ATCC Cat. #CRL-2755, RRID: CVCL_1923), Article Title: Tumor cells impair immunological synapse formation via central nervous system-enriched metabolite. Article Snippet: Article Tumor cells impair immuno logical synapse formation via central nervous system-enriched metabolite |